Back to today’s briefing

Story perspectives

Eli Lilly Unveils Game-Changing Obesity Treatments by 2026

1/26/2025

33 6

Summary

Story summary

Eli Lilly is making strides in obesity treatment with orforglipron, a weight-loss pill designed to rival the effectiveness of Ozempic without the need for injections. Additionally, their retatrutide shot promises results comparable to bariatric surgery. With a vision for a convenient annual obesity shot, Eli Lilly aims to revolutionize care by 2026.

1 of 1

Story summary

Eli Lilly is making strides in obesity treatment with orforglipron, a weight-loss pill designed to rival the effectiveness of Ozempic without the need for injections. Additionally, their retatrutide shot promises results comparable to bariatric surgery. With a vision for a convenient annual obesity shot, Eli Lilly aims to revolutionize care by 2026.